A636P testing in Ashkenazi Jews

Keyphrases

• Ashkenazi Jews 100%
• Hereditary Colorectal Cancer Syndromes 60%
• Founder mutation 40%
• Jewish Population 40%
• MSH2 40%
• Jewish Patients 40%
• Personal Experience 20%
• Early Onset 20%
• High Risk 20%
• Colorectal Cancer 20%
• Testing Protocol 20%
• Intermediate Risk 20%
• MLH1 20%
• DNA Mismatch Repair Genes 20%

Medicine and Dentistry

• Hereditary Nonpolyposis Colorectal Cancer 100%
• DNA Mismatch Repair 33%
• Cancer Syndrome 33%
• Onset Age 33%
• Personal Experience 33%
• Colorectal Carcinoma 33%
• Hereditary Colorectal Cancer 33%

Biochemistry, Genetics and Molecular Biology

• MSH2 100%
• DNA Mismatch Repair 50%
• MLH1 50%
• Personal Experience 50%